112 Results for "

estrogen receptor antagonist

" in MedChemExpress (MCE) Product Catalog:
Products (112)

112 Results for "estrogen receptor antagonist" in MCE Product Catalog:

145
145 Publications Verification
Cat. No.: HY-13636
CAS No.: 129453-61-8
Purity:  99.92%
Synonyms: ICI 182780; ZD 9238; ZM 182780
Fulvestrant (ICI 182780) is a pure antiestrogen and a potent estrogen receptor (ER) antagonist with an IC50 of 9.4 nM. Fulvestrant is also a GPR30 agonist. Fulvestrant effectively inhibits the growth of ER-positive MCF-7 cells with an IC50 of 0.29 nM. Fulvestrant also induces autophagy and has antitumor efficacy .
loading...
    loading...
43
43 Cited Publications
Cat. No.: HY-103449
CAS No.: 1161002-05-6
Purity:  ≥99.0%
Target:  

Estrogen Receptor/ERR

Research Areas:  

Cancer

G15 is a high affinity and selective G-protein-coupled estrogen receptor (GPER/GPR30) antagonist with a Ki of 20 nM .
loading...
    loading...
34
34 Cited Publications
Cat. No.: HY-103456
CAS No.: 805239-56-9
Purity:  99.70%
Target:  

Estrogen Receptor/ERR

Research Areas:  

Cancer

PHTPP is a selective estrogen receptor β (ERβ) antagonist with 36-fold selectivity over ERα .
loading...
    loading...
29
29 Cited Publications
Cat. No.: HY-12870
CAS No.: 1639042-08-2
Purity:  99.28%
Target:  

Estrogen Receptor/ERR

Research Areas:  

Cancer

AZD9496 is an effective, selective estrogen receptor (ERα) antagonist with an IC50 of 0.28 nM. AZD9496 is an orally active, selective estrogen receptor degrader (SERD).
loading...
    loading...
29
29 Cited Publications
Cat. No.: HY-12870A
CAS No.: 1639042-28-6
Purity:  99.35%
Target:  

Estrogen Receptor/ERR

Research Areas:  

Cancer

AZD9496 maleate is a potent and selective estrogen receptor (ERα) antagonist with IC50 of 0.28 nM. AZD9496 maleate is an orally bioavailable selective oestrogen receptor degrader (SERD).
loading...
    loading...
20
20 Cited Publications
Cat. No.: HY-13738A
CAS No.: 82640-04-8
Purity:  99.78%
Synonyms: Keoxifene hydrochloride; LY156758; LY139481 hydrochloride
Raloxifene hydrochloride (Keoxifene hydrochloride) is a second generation selective and orally active estrogen receptor modulator. Raloxifene hydrochloride produces estrogen-agonistic effects on bone and lipid metabolism and estrogen-antagonistic effects on uterine endometrium and breast tissue .
loading...
    loading...
20
20 Cited Publications
Cat. No.: HY-13738
CAS No.: 84449-90-1
Purity:  99.62%
Synonyms: Keoxifene; LY156758 free base; LY139481
Target:  

Estrogen Receptor/ERR

Research Areas:  

Cancer

Raloxifene (Keoxifene) is a benzothiophene-derived selective estrogen receptor modulator (SERM). Raloxifene has estrogen-agonistic effects on bone and lipids and estrogen-antagonistic effects on the breast and uterus. Raloxifene is used for breast cancer and osteoporosis research .
loading...
    loading...
17
17 Cited Publications
Cat. No.: HY-103454
CAS No.: 911295-24-4
Purity:  99.54%
Research Areas:  

Endocrinology Cancer

MPP dihydrochloride is a potent and selective ER (estrogen receptor) modulator. MPP dihydrochloride induces significant apoptosis in the endometrial cancer and oLE cell lines. MPP dihydrochloride reverses the positive effects of beta-estradiol. MPP dihydrochloride has mixed agonist/antagonist action on murine uterine ERalpha in vivo .
loading...
    loading...
17
17 Cited Publications
Cat. No.: HY-103454B
CAS No.: 2863676-89-3
Purity:  99.28%
Research Areas:  

Endocrinology Cancer

MPP hydrochloride is a potent and selective ER (estrogen receptor) modulator. MPP hydrochloride induces significant apoptosis in the endometrial cancer and oLE cell lines. MPP hydrochloride reverses the the positive effects of beta-estradiol. MPP hydrochloride has mixed agonist/antagonist action on murine uterine ERalpha in vivo .
loading...
    loading...
8
8 Cited Publications
Cat. No.: HY-136255
CAS No.: 2222844-89-3
Purity:  99.32%
Synonyms: AZD-9833
Target:  

Estrogen Receptor/ERR

Research Areas:  

Cancer

Camizestrant (AZD-9833) is a potent and orally active estrogen receptor (ER) antagonist. Camizestrant is used for the study of ER + HER2-advanced breast cancer .
loading...
    loading...
7
7 Cited Publications
Cat. No.: HY-B0412
CAS No.: 50-27-1
Synonyms: Oestriol
Estriol (Oestriol), an orally active estrogen, is a ERα and ERβ agonist. Estriol is a potent GPR30 antagonist in estrogen receptor-negative breast cancer cells. Estriol can ameliorate disease severity through immunomodulatory mechanisms that decrease tissue inflammation. Estriol has powerful proconvulsant effects .
loading...
    loading...
6
6 Cited Publications
Cat. No.: HY-109176
CAS No.: 1953133-47-5
Purity:  99.52%
Synonyms: GDC-9545; RG6171
Target:  

Estrogen Receptor/ERR

Research Areas:  

Endocrinology Cancer

Giredestrant (GDC-9545) is an orally active, full, selective Estrogen receptor α (ERα) degrader and antagonist with a DC50 of 0.03 nM. Giredestrant promotes the degradation of ERα protein, including the ESR1 Y537S mutant ERα. Giredestrant reduces uterine wet weight in immature rats and induces a low cuboidal phenotype in their endometrial epithelium. Giredestrant induces tumor regression in both ESR1 Y537S mutant and wild-type ERα tumor models. Giredestrant can be used for the research of ER + breast cancer .
loading...
    loading...
5
5 Cited Publications
Cat. No.: HY-118861
CAS No.: 15690-57-0
Synonyms: (E)-Clomiphene; trans-Clomiphene; Enclomifene
Target:  

Estrogen Receptor/ERR

Research Areas:  

Metabolic Disease Endocrinology

Enclomiphene ((E)-Clomiphene) is a potent and orally active non-steroidal estrogen receptor antagonist, with antioestrogenic property. Enclomiphene can be used for the research of ovarian dysfunction, testosterone deficiency, male hypogonadism and type 2 diabetes .
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-133017
CAS No.: 2114339-57-8
Purity:  99.79%
Synonyms: SAR439859
Target:  

Estrogen Receptor/ERR

Research Areas:  

Cancer

SAR439859 (compound 43d) is an orally active, non-steroidal, and selective estrogen receptor degrader (SERD). SAR439859 is an effective ER antagonist with ER degradation activity, an EC50 of 0.2 nM. SAR439859 can show potent anti-tumor effects and limited cross-resistance in ER + breast cancer.
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-112596
CAS No.: 2052130-80-8
Purity:  99.44%
Target:  

Estrogen Receptor/ERR

Research Areas:  

Cancer

H3B-6545 is an oral, selective estrogen receptor covalent antagonist (SERCA) for the research of metastatic ER-positive, HER2-negative breast cancer .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-111484
CAS No.: 1642297-01-5
Purity:  99.98%
Synonyms: SRN-927
Target:  

Estrogen Receptor/ERR

Research Areas:  

Cancer

GDC-0927 (SRN-927) is a potent, non-steroidal, orally bioavailable, selective estrogen receptor antagonist .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-112596A
CAS No.: 2052132-51-9
Purity:  99.16%
Target:  

Estrogen Receptor/ERR

Research Areas:  

Cancer

H3B-6545 hydrochloride is an oral, selective estrogen receptor covalent antagonist (SERCA) for the research of metastatic ER-positive, HER2-negative breast cancer .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-16023A
CAS No.: 182167-02-8
Synonyms: EM-652; SCH 57068
Target:  

Estrogen Receptor/ERR

Research Areas:  

Cancer

Acolbifene (EM-652), the active metabolite of EM800, is an orally active pure antiestrogen and selective estrogen receptor antagonist. Acolbifene (EM-652) inhibits estradiol (E2)-induced transcriptional activity of ERα (IC50 = 2 nM) and ERβ (IC50 = 0.4 nM). Acolbifene (EM-652) possesses potent and pure anticarcinogenic properties .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-145572
CAS No.: 2408840-26-4
Purity:  99.02%
Synonyms: LY-3484356
Target:  

Estrogen Receptor/ERR

Research Areas:  

Cancer

Imlunestrant (LY-3484356) is an orally active, potent and selective estrogen receptor degrader (SERD) with pure antagonistic properties. Imlunestrant results in sustained inhibition of ER-dependent gene transcription and cell growth. Imlunestrant can be used for the research of ER-positive (ER+) advanced breast cancer (aBC) and endometrial endometrioid cancer (EEC) .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-118861A
CAS No.: 7599-79-3
Purity:  99.96%
Synonyms: (E)-Clomiphene citrate; trans-Clomiphene citrate; Enclomifene citrate
Target:  

Estrogen Receptor/ERR

Research Areas:  

Metabolic Disease Endocrinology

Enclomiphene ((E)-Clomiphene) citrate is a potent and orally active non-steroidal estrogen receptor antagonist, with antioestrogenic property. Enclomiphene citrate can be used for the research of ovarian dysfunction, testosterone deficiency, male hypogonadism and type 2 diabetes .
loading...
    loading...